Adelaide Research & Scholarship
Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/88978
| Citations | ||
| Scopus | Web of Science® | Altmetric |
|---|---|---|
|
?
|
?
|
|
| Type: | Journal article |
| Title: | Imatinib trough levels in chronic myelogenous leukemia: does one dose fit all? |
| Author: | Yeung, D.T. White, D.L. |
| Citation: | Leukemia and Lymphoma, 2011; 52(2):165-167 |
| Publisher: | Informa Healthcare |
| Issue Date: | 2011 |
| ISSN: | 1042-8194 1029-2403 |
| Statement of Responsibility: | David T. Yeung & Deborah L. White |
| Keywords: | Humans Benzamides Piperazines Pyrimidines Antineoplastic Agents Gastric Bypass Intestinal Absorption Leukemia, Myelogenous, Chronic, BCR-ABL Positive Imatinib Mesylate |
| Rights: | © 2011 Informa UK, Ltd. |
| DOI: | 10.3109/10428194.2010.540362 |
| Published version: | http://dx.doi.org/10.3109/10428194.2010.540362 |
| Appears in Collections: | Aurora harvest 7 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.